Cyrus Mirsaidi

Cyrus Mirsaidi brings both practical and strategic senior management experience for young start-ups to fortune 100 companies, with a proven track record in Biotech. As an Operating Partner for Bridgewest Group, Cyrus provides a wealth of industry knowledge and leadership insight, guiding CEOs of Bridgewest Group portfolio companies in complex business matters. In addition, Cyrus currently serves as a Board Advisor for BioDuro-Sundia, after serving as President and CEO for the company for over 5 years. He held several senior level management positions in his ten-year career at Nichols Institute Diagnostics (a division of Quest Diagnostics). As general manager and executive director at Ontogen, a small molecule discovery company, he managed operations of a subsidiary focused on high throughput synthesis and purification of novel chemical compounds. Cyrus served as Vice President at AltheaDx, a spin-out from Althea Technologies, a San Diego biologics GMP manufacturing company, and most recently served as CEO and founder of Molecular Response, LLC, a CRO focused on translational oncology.